These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16650801

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.
    Leung CY, Park J, De Schutter JW, Sebag M, Berghuis AM, Tsantrizos YS.
    J Med Chem; 2013 Oct 24; 56(20):7939-50. PubMed ID: 23998921
    [Abstract] [Full Text] [Related]

  • 25. Biochemical and molecular mechanisms of action of bisphosphonates.
    Rogers MJ, Crockett JC, Coxon FP, Mönkkönen J.
    Bone; 2011 Jul 24; 49(1):34-41. PubMed ID: 21111853
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
    Sanders JM, Ghosh S, Chan JM, Meints G, Wang H, Raker AM, Song Y, Colantino A, Burzynska A, Kafarski P, Morita CT, Oldfield E.
    J Med Chem; 2004 Jan 15; 47(2):375-84. PubMed ID: 14711309
    [Abstract] [Full Text] [Related]

  • 29. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
    Russell RG, Watts NB, Ebetino FH, Rogers MJ.
    Osteoporos Int; 2008 Jun 15; 19(6):733-59. PubMed ID: 18214569
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bisphosphonates: how do they work?
    Papapoulos SE.
    Best Pract Res Clin Endocrinol Metab; 2008 Oct 15; 22(5):831-47. PubMed ID: 19028359
    [Abstract] [Full Text] [Related]

  • 33. Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.
    Lühe A, Künkele KP, Haiker M, Schad K, Zihlmann C, Bauss F, Suter L, Pfister T.
    Toxicol In Vitro; 2008 Jun 15; 22(4):899-909. PubMed ID: 18325729
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates.
    Kimmel DB.
    J Dent Res; 2007 Nov 15; 86(11):1022-33. PubMed ID: 17959891
    [Abstract] [Full Text] [Related]

  • 35. Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis.
    Savino S, Toscano A, Purgatorio R, Profilo E, Laghezza A, Tortorella P, Angelelli M, Cellamare S, Scala R, Tricarico D, Marobbio CMT, Perna F, Vitale P, Agamennone M, Dimiccoli V, Tolomeo A, Scilimati A.
    Eur J Med Chem; 2018 Oct 05; 158():184-200. PubMed ID: 30216851
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.
    Nishiguchi T, Akiyoshi T, Anami S, Nakabayashi T, Matsuyama K, Matzno S.
    J Pharm Pharmacol; 2009 Jun 05; 61(6):781-8. PubMed ID: 19505369
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.